Cargando…
Structure–Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
[Image: see text] The design, synthesis, and evaluation of the potency of new isoform-selective inhibitors of sphingosine kinases 1 and 2 (SK1 and SK2), the enzyme that catalyzes the phosphorylation of d-erythro-sphingosine to produce the key signaling lipid, sphingosine 1-phosphate, are described....
Autores principales: | Baek, Dong Jae, MacRitchie, Neil, Anthony, Nahoum G., Mackay, Simon P., Pyne, Susan, Pyne, Nigel J., Bittman, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848335/ https://www.ncbi.nlm.nih.gov/pubmed/24164513 http://dx.doi.org/10.1021/jm401399c |
Ejemplares similares
-
Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension
por: MacRitchie, Neil, et al.
Publicado: (2016) -
Sphingosine kinase 2 and multiple myeloma
por: Pyne, Nigel J., et al.
Publicado: (2017) -
The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells
por: Tonelli, Francesca, et al.
Publicado: (2013) -
Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
por: Pyne, Susan, et al.
Publicado: (2012) -
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
por: McNaughton, Melissa, et al.
Publicado: (2016)